體外診斷藥品包裝市場：按產品、最終用戶分類 - 2023-2030 年全球預測

體外診斷包裝市場預計將從 2022 年的 68.2 億美元增加到 2030 年的 114.4 億美元，預測期內年複合成長率為 6.68%。

全球體外診斷藥物包裝市場

FPNV定位矩陣

FPNV定位矩陣是評估體外診斷包裝市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。這個富有洞察力的框架使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧洞察。

本報告解決了以下關鍵問題：

1.體外診斷藥物包裝市場的市場規模與預測為何？

2. 體外診斷藥品包裝市場中哪些產品、細分市場、應用和領域具有最高的投資潛力？

3.體外診斷藥物包裝市場的競爭策略窗口有哪些？

4.體外診斷藥物包裝市場的最新技術趨勢和法律規範是什麼？

5.體外診斷藥品包裝市場主要供應商的市場佔有率為何？

6.進入體外診斷包裝市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 慢性疾病和感染疾病的傳播
    • 現場檢測的成長趨勢
    • 個人化醫療方法的趨勢
  • 抑制因素
    • 體外診斷包的製造成本很高
  • 機會
    • 體外診斷智慧包裝簡介
    • 持續研究和開發永續的體外診斷包裝生產
  • 任務
    • 體外診斷包裝設計的複雜性
• 市場區隔分析
• 市場趨勢分析
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範

第6章 體外診斷藥物包裝市場：依產品

• 瓶子
• 關閉
• 管子
• 小瓶

第7章 體外診斷藥品包裝市場：依最終用戶分類

• 學術機構
• 臨床實驗室
• 醫院

第8章 美洲體外診斷藥品包裝市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太體外診斷藥品包裝市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲體外診斷藥品包裝市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市場佔有率分析：主要企業
• 競爭情境分析：主要企業

第12章競爭產品組合

• 主要公司簡介
  • Amcor PLC
  • APTARGROUP, INC.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • DWK Life Sciences LLC
  • James Alexander Corporation
  • Narang Medical Limited
  • Oliver-Tolas Healthcare Packaging BV
  • PerkinElmer Inc.
  • PMMI Media Group
  • QIAGEN NV
  • Siemens AG
  • SONIC PACKAGING
  • Thermofisher Scientific Inc.
  • VITLAB GmbH
• 主要產品系列

第13章附錄

• 討論指南
• 關於許可證和定價

The In-Vitro Diagnostics Packaging Market is projected to reach USD 11.44 billion by 2030 from USD 6.82 billion in 2022, at a CAGR of 6.68% during the forecast period.

Global In-Vitro Diagnostics Packaging Market

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the In-Vitro Diagnostics Packaging Market.

Based on Product, market is studied across Bottles, Closures, Tubes, and Vials. The Closures is projected to witness significant market share during forecast period.

Based on End User, market is studied across Academic Institutes, Clinical Laboratories, and Hospitals. The Academic Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the In-Vitro Diagnostics Packaging Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape In-Vitro Diagnostics Packaging Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the In-Vitro Diagnostics Packaging Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, APTARGROUP, INC., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, DWK Life Sciences GmbH, DWK Life Sciences LLC, James Alexander Corporation, Narang Medical Limited, Oliver-Tolas Healthcare Packaging B.V., PerkinElmer Inc., PMMI Media Group, QIAGEN N.V., Siemens AG, SONIC PACKAGING, Thermofisher Scientific Inc., and VITLAB GmbH.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the In-Vitro Diagnostics Packaging Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the In-Vitro Diagnostics Packaging Market?

3. What is the competitive strategic window for identifying opportunities in the In-Vitro Diagnostics Packaging Market?

4. What are the latest technology trends and regulatory frameworks in the In-Vitro Diagnostics Packaging Market?

5. What is the market share of the leading vendors in the In-Vitro Diagnostics Packaging Market?

6. Which modes and strategic moves are suitable for entering the In-Vitro Diagnostics Packaging Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. In-Vitro Diagnostics Packaging Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic and infectious diseases
    • 5.1.1.2. Rising trend of point-of-care testing
    • 5.1.1.3. Inclination toward personalized medicine approach
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of production of in-vitro diagnostic packaging
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of smart packaging for in-vitro diagnostics
    • 5.1.3.2. Ongoing R&D for the production of sustainable in-vitro diagnostic packaging
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity in designing in-vitro diagnostic packaging
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. In-Vitro Diagnostics Packaging Market, by Product

• 6.1. Introduction
• 6.2. Bottles
• 6.3. Closures
• 6.4. Tubes
• 6.5. Vials

7. In-Vitro Diagnostics Packaging Market, by End User

• 7.1. Introduction
• 7.2. Academic Institutes
• 7.3. Clinical Laboratories
• 7.4. Hospitals

8. Americas In-Vitro Diagnostics Packaging Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific In-Vitro Diagnostics Packaging Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa In-Vitro Diagnostics Packaging Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Amcor PLC
  • 12.1.2. APTARGROUP, INC.
  • 12.1.3. Becton, Dickinson and Company
  • 12.1.4. Bio-Rad Laboratories, Inc.
  • 12.1.5. Corning Incorporated
  • 12.1.6. DWK Life Sciences GmbH
  • 12.1.7. DWK Life Sciences LLC
  • 12.1.8. James Alexander Corporation
  • 12.1.9. Narang Medical Limited
  • 12.1.10. Oliver-Tolas Healthcare Packaging B.V.
  • 12.1.11. PerkinElmer Inc.
  • 12.1.12. PMMI Media Group
  • 12.1.13. QIAGEN N.V.
  • 12.1.14. Siemens AG
  • 12.1.15. SONIC PACKAGING
  • 12.1.16. Thermofisher Scientific Inc.
  • 12.1.17. VITLAB GmbH
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET RESEARCH PROCESS
• FIGURE 2. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2022 VS 2030
• FIGURE 3. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. IN-VITRO DIAGNOSTICS PACKAGING MARKET DYNAMICS
• FIGURE 7. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 8. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 10. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 12. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 14. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 20. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 6. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLOSURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 11. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 101. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 102. IN-VITRO DIAGNOSTICS PACKAGING MARKET LICENSE & PRICING